-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
June 09, 2021 - TEP #2 Methods Yes [Were the methods clearly described] Noted. … The study by Kocher is
described under KQ3. … Key attributes of studies were described. … The limitations are clearly described. No
important literature was omitted.
Noted. … The
limitations of the studies are adequately
described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
May 04, 2015 - We are confused about this
comment as spoon feeding is not
described in this section at all. … Limitations are described adequately. I am
not aware of any studies that were omitted. … Bleeding was typically
described as minor and limited. … Few studies described
what specific methods they used to collect harms data.” … We have added the reference to the
one case of mucocele described in
the literature.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
September 10, 2014 - We have described the items we
considered in the assessment of risk of bias in the
revised report. … Doesn’t really make sense as described. … Results Are the characteristics of the studies clearly described? … Methods Methods described under data synthesis are quite strong – nicely
done!!
Thank you. … The limitations are adequately
described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - The reader is left uncertain
as to whether the system being described is automated in some
way or not … As described above, we have
restructured KQ1 to focus on: ability to
assess cough frequency or cough … As described above, we have
restructured KQ1 to focus on the
ability of cough measurement tools to … Unfortunately, during our systematic
review we found almost no studies
that conducted and described … The
Discussion/Conclusion and Executive
Summary have been amended to
correct these issues
As described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
December 17, 2013 - of the research
team (LG, CL) for inclusion or exclusion on the basis of the eligibility criteria described … Race (Percentages)
Other cancer characteristics
Intervention characteristics Type(s) of imaging described
-
effectivehealthcare.ahrq.gov/products/roadmap-interventions/white-paper
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
April 10, 2025 - However, we only identified one study that met
inclusion criteria for this Key Question, which is
described … trial enrolled children in foster care or
involved in the welfare system but for those that
did, we described … between intervention and
control groups are reported in the KQ 2 Key
Points and Summary of Findings and described … The Risk of Bias for the included studies was
assessed using standardized AHRQ methods, as
described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
April 01, 2012 - The enhancements described below will
be incorporated into Phase 2 of our Distributed Research Network … The components of the DRN System Architecture are described in the table in Appendix
A1. … Rights button Presents the Rights Selection form as described in
section 0 on page 24. … Appendix ‘B’ describes the latest changes made to the requirements
described in this section. … Permissions button Presents the Data Mart Permissions form as described below.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
August 23, 2013 - To
further complicate this issue, not all studies described in detail whether
certain factors were … The characteristics of the studies are clearly
described. … Studies are well described and appropriate. … The limitations of the review/sudies are described
adequately. … The research gaps for all Key
Questions have been described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
November 20, 2024 - Similarly, many
individual LCAs in healthcare can be described as
presenting "frameworks" for completing … Introduction Page 1 line 13, ISO has published an entire
sequence of LCA standards, not only the two
described … KI reviewer #1 Methods No comment N/A
Peer reviewer #1 Methods The Methods are clearly described.
-
effectivehealthcare.ahrq.gov/sites/default/files/blumenthal-presentation.pdf
May 29, 2025 - We looked
at when
they described
how they made this medical decision, whether they deferred … to the F rosh
study with
the 48 focus group
participants, these participants frequently described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - of types of interventions can be implemented to integrate palliative care into ambulatory
care, as described … : Criteria for inclusion and
exclusion of documents are based on the Key Questions and are briefly described … Criteria
Content Relevant to any of the interventions listed in
KQ and PICOTS
Population As described … and exclusion of qualitative and mixed methods studies will be
based on the Key Questions and are described … Tables will also include
details of implementation of the interventions as described in these studies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-disposition-comments.pdf
April 07, 2025 - Qualitative reports of
contextual factors described a physician champion
leaving the practice, which … real-time tracking of
patients was identified as a facilitator in improving
followup.81 One study described … Some of these are in
described in Figure 14. … This section effectively described the purposes of the
report; the need for quality measures for vision … Qualitative reports of contextual factors described a physician champion leaving the practice, which
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth_research-protocol.pdf
August 11, 2015 - Published Literature search
The guiding questions described above will be used to create search strategies … Process for Selecting Studies
The guiding questions described above will be used to determine eligibility
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-protocol.pdf
August 23, 2023 - devices and
evaluation of material efficiency in processes and procedures.1-8 The framework for LCA
is described … What limitations of these frameworks have been described?
GQ2. … We will broadly characterize the frameworks by described scope
(e.g., cradle to grave). … evidence-based status (e.g., the
components are based on empirical data), defined population (framework target described
-
effectivehealthcare.ahrq.gov/sites/default/files/goldstrom.pdf
May 29, 2025 - We fund something
called the Children’s Mental Health Initiative, which is described on this
slide
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-surgical-report-cards.pdf
November 01, 2023 - Two examples of collaborative program implementations were
described: the Tennessee Surgical Quality … First, Davis et al. in
2017 described a collaboration among 20 hospitals under ACS NSQIP and Texas … In 2016, Poulouse et al. described the design and implementation of the
Americas Hernia Society Quality … Similarly, Asher et al in 2016 described the establishment of the National
Neurosurgery Quality and … Was the Test/Service/
Intervention Clearly
Described and
Delivered Consistently
Across the Study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-executive-sum.pdf
January 01, 2025 - met criteria for this review on other plant-
based compounds such as kratom.
3
described … Results
The included RCTs are described in Table B and the included observational studies
are described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
October 01, 2011 - Regarding the need to describe which GI harms were
evaluated, this is described in the Methods section … As described in the results for aspirin (page 51, starting line
50): “In these studies, the dose of … See above regarding possibility of confounding, which are
described as methodological flaws in a number … The questions are clinically
relevant and the population to which these results
apply is well described … The outcomes of interest are described in detail in the Methods
(page 35 starting line 36).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_technical-brief.pdf
January 01, 2012 - The process has been described by
providers, patient organizations, and others. … This process has been described by
a number of experts from the point of identification of a need for … The guidance described
below represents individual or consensus expert opinion. … They
described six steps24 (Table 1) and emphasized a collaborative and consumer-centered approach. … The guidelines further described “good practice” for each of the service delivery steps.